187 related articles for article (PubMed ID: 16420663)
1. Inhaled beta-2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury.
Manocha S; Gordon AC; Salehifar E; Groshaus H; Walley KR; Russell JA
Crit Care; 2006 Feb; 10(1):R12. PubMed ID: 16420663
[TBL] [Abstract][Full Text] [Related]
2. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
Gates S; Perkins GD; Lamb SE; Kelly C; Thickett DR; Young JD; McAuley DF; Snaith C; McCabe C; Hulme CT; Gao Smith F
Health Technol Assess; 2013 Sep; 17(38):v-vi, 1-87. PubMed ID: 24028755
[TBL] [Abstract][Full Text] [Related]
3. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
4. The beta-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial.
Perkins GD; McAuley DF; Thickett DR; Gao F
Am J Respir Crit Care Med; 2006 Feb; 173(3):281-7. PubMed ID: 16254268
[TBL] [Abstract][Full Text] [Related]
5. Effects of salbutamol on exhaled breath condensate biomarkers in acute lung injury: prospective analysis.
Roca O; Gómez-Ollés S; Cruz MJ; Muñoz X; Griffiths MJ; Masclans JR
Crit Care; 2008; 12(3):R72. PubMed ID: 18513388
[TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.
; Matthay MA; Brower RG; Carson S; Douglas IS; Eisner M; Hite D; Holets S; Kallet RH; Liu KD; MacIntyre N; Moss M; Schoenfeld D; Steingrub J; Thompson BT
Am J Respir Crit Care Med; 2011 Sep; 184(5):561-8. PubMed ID: 21562125
[TBL] [Abstract][Full Text] [Related]
7. Concomitant inhaled corticosteroid resensitises cardiac beta2-adrenoceptors in the presence of long-acting beta2-agonist therapy.
Aziz I; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jul; 54(5):377-81. PubMed ID: 9754979
[TBL] [Abstract][Full Text] [Related]
8. Effect of salmeterol is independent of previously inhaled salbutamol: a clinical controlled study.
Wilcke JT; Iversen ET; Kok-Jensen A
Lung; 1998; 176(2):133-9. PubMed ID: 9500298
[TBL] [Abstract][Full Text] [Related]
9. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.
Dennis SM; Sharp SJ; Vickers MR; Frost CD; Crompton GK; Barnes PJ; Lee TH
Lancet; 2000 May; 355(9216):1675-9. PubMed ID: 10905242
[TBL] [Abstract][Full Text] [Related]
10. First do no harm: surrogate endpoints and the lesson of β-agonists in acute lung injury.
Lakshminarayana PH; Kahn JM
Crit Care; 2012 Jun; 16(3):314. PubMed ID: 22731873
[TBL] [Abstract][Full Text] [Related]
11. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment].
Watanabe N; Makino S; Kihara N; Fukuda T
Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083
[TBL] [Abstract][Full Text] [Related]
12. Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27.
Lee DK; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jan; 57(1):100-4. PubMed ID: 14678347
[TBL] [Abstract][Full Text] [Related]
13. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
[TBL] [Abstract][Full Text] [Related]
15. Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: a randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome.
Perkins GD; Gates S; Lamb SE; McCabe C; Young D; Gao F
Trials; 2011 May; 12():113. PubMed ID: 21554679
[TBL] [Abstract][Full Text] [Related]
16. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
Cockcroft DW; Swystun VA; Bhagat R
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.
Gao Smith F; Perkins GD; Gates S; Young D; McAuley DF; Tunnicliffe W; Khan Z; Lamb SE;
Lancet; 2012 Jan; 379(9812):229-35. PubMed ID: 22166903
[TBL] [Abstract][Full Text] [Related]
18. High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children.
Decimo F; Maiello N; Miraglia Del Giudice M; Amelio R; Capristo C; Capristo AF
Int J Immunopathol Pharmacol; 2009; 22(2):363-70. PubMed ID: 19505390
[TBL] [Abstract][Full Text] [Related]
19. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease.
McCrory DC; Brown CD
Cochrane Database Syst Rev; 2001; 2001(2):CD002984. PubMed ID: 11406052
[TBL] [Abstract][Full Text] [Related]
20. Cilomilast (Ariflo) does not potentiate the cardiovascular effects of inhaled salbutamol.
Murdoch RD; Cowley H; Kelly J; Higgins R; Webber D
Pulm Pharmacol Ther; 2002; 15(6):521-7. PubMed ID: 12493339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
